Screening for AF in Primary Care
Atrial fibrillation (AF) is associated with significant impairments in functional capacity and health-related quality of life, as well as with an increased morbidity and mortality. AF is independently associated with a 1.5- to 4-fold increased risk of mortality, predominantly due to increased risk of thromboembolic events (stroke) and ventricular dysfunction.
In this expert brief, Dr. Isabelle Nault and Dr. Bruno Bernucci discuss the benefits of screening for AF, who should be screened, and various screening and imaging methods. They will also touch on the use of oral anticoagulants to reduce the risk of stroke associated with AF.
This program is made possible through educational support from the BMS/Pfizer Alliance.
This self-learning program has been certified by the College of Family Physicians of Canada for up to 0.25 Mainpro+ credits.
Cert+ Program ID#: 194824
Isabelle Nault, MD, FRCPC
Bruno Bernucci, MD
Anas Nsier, MD
Sy Lam, MD, CCFP, FCFP
Parmjit Sohal, MD, PhD, CCFP, FCFP
Upon completion of this continuing education program, participants will be better able to:
- Discuss when anticoagulation therapy is warranted to prevent stroke in patients with atrial fibrillation (AF);
- Describe the benefits of screening for AF as well as the most effective types of screening;
- Implement appropriate treatment strategies individualized for each patient.